This graph may schematically represent a transduction network consisting of a crosstalk between two pathways converging with opposite interactions in the same genetic system.
Intuitively, a BPM could be an artifact of ascertainment bias if it turned out that all or nearly all pairs of genes tested for synthetic lethality turned out to lie between the two pathways, with few or no tests having been performed between pairs of genes that lie within the same pathway.
Interestingly, the proteins in the paths between these two pathways with the TGF-beta and Proteasome pathways behave differently between the HF and LF group (Additional file 1, Figure S12).
The PBPK model integrates the competition between the two pathways with the physiological determinants of internal dose to predict the nonlinear exposure dose relationship for both pathways.
The reactive enamine geometry differs between the two pathways, with the s -cis enamine yielding the major enantiomer and the s -trans enamine yielding the minor enantiomer, as these conformations enable both pathways to benefit from stabilizing hydrogen bonding interactions between ester and thiourea.
Off-target effects associated with targeted therapies are often attributed to crosstalk, which refers to inter-pathway molecular interactions arising because of explicit regulatory feedback connections between two pathways or because two pathways share one or more molecular components.
Among 18 SLGIs between two pathways, 11 are novel predictions.
This review will examine the parallels between and intersections of these two pathways, with emphasis placed on their relevance in colorectal and pancreatic cancers.
For Group B, i-GSEA4GWAS v2 shared 27 pathways and two pathways with GenGen and SRT separately; GenGen and SRT shared three pathways, in which, two pathways were shared by three tools.
When cut-off value of 0.5 was used to distinguish if the two pathways interact with each other, 41 out of 45 pathway pairs are consistent between two pathway databases.
